Urologic Disease Therapy
Submission DeadlineMay 20, 2020

Online submission system: http://www.sciencepublishinggroup.com/login

Lead Guest Editor
Shen Zhi-Yong
Department of Urology, Guizhou province cancer hospital, Guiyang, Guizhou, China
Guest Editors
  • Shi Jiaqi
    Department of Urology, Guizhou Medical University Affiliated Hospital, Guizhou, China
  • Ma Honggui
    Department of Urology, Guizhou Medical University Affiliated Hospital, Guizhou, China
  • Chen Xulong
    Department of Urology, Guizhou Medical University Affiliated Hospital, Guizhou, China
  • Zhong Quliang
    Department of Urology, Guizhou Medical University Affiliated Hospital, Guizhou, China
  • Han Yu
    Department of Urology, Guizhou Medical University Affiliated Hospital, Guizhou, China
  • Zhang Facai
    Department of Urology, Guizhou Medical University Affiliated Hospital, Guizhou, China
Introduction
Special Issue on Urologic Disease Therapy publishes papers in the field of Urologic disease therapy, defining urologic disease therapy is the treatment of individual who have urologic disease for example: urolithiasis, Urologic tumor, Benign prostatic hyperplasia etc. The journal presents original papers, reviews and letters. The primary goal of this journal is to improve the understanding of Urologic disease diagnose and therapy, and by presenting the evidence based work. The journal is addressed to urologists and other specialists interested in urologic disease diagnose and therapy research.
Aims and Scope:
  1. Urolithiasis
  2. Renal carcinoma
  3. Blader cancer
  4. Reproductive system cancer
  5. Benign prostatic hyperplasia
  6. Prostate cancer
Guidelines for Submission
Manuscripts should be formatted according to the guidelines for authors
(see: http://www.sciencepublishinggroup.com/journal/guideforauthors?journalid=283).

Please download the template to format your manuscript.

ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186